Market News How it works Learn FAQ
| TGL 0.2897 30.79% | SRTM 0.6164 43.25% | NU 11.845 -21.87% | GCDT 0.1604 -8.92% | EWZ 31.98 -24.91% | NWGL 0.0808 -1.46% | SHFS 0.1254 -5.29% | RBNE 0.183 -3.68% | CLRO 4.2705 31.40% | SPRC 1.635 50.00% | SOXL 87.29 4.46% | BBD 2.9088 -28.53% | VBIO 0.785 -16.49% | RENT 2.85 23.91% | ITUB 7.63 -21.10% | PBR 21.675 -17.14% | SOXS 50.2 -4.31% | TSLL 10.68 9.43% | SPCX 147.12 -0.25% | XP 14.42 -52.58% | XXII 0.1032 -47.80% | GPUS 0.1583 -6.28% | WFF 0.0741 -7.38% | KORU 10.59 0.09% | CRWV 52.0841 -3.97% | IREN 24.13 -3.11% | STNE 7.83 -31.79% | SQQQ 39.02 -1.66% | PRSO 0.35 -7.51% | NOK 8.44 3.69% | INTR 4.751 -33.92% | MYND 0.2219 -7.54% | TQQQ 67.37 1.63% | INTC 88.11 1.32% | VALE 12.27 -1.05% | NVDA 214.88 1.86% | TSLA 389.99 4.77% | VZ 43.45 -2.71% | IBIT 44.9769 -2.14% | WORX 2.2101 0.92% | YMAT 2.25 9.76% | AZTR 0.9102 1,173.01% | JBLU 2.4312 -7.38% | STLA 4.105 1.11% | WULF 11.36 0.35% | T 21.075 0.69% | IRE 2.9 -6.15% | PAGS 8.6 -24.83% | META 631.35 -1.75% | NBIS 151.07 -4.83%
DRDarioHealth Corp. logo

DarioHealth Corp. (DRIO)

NASDAQ Capital Market · Currency in USD
$3.94 ▲ +0.17 (+4.51%)
As of Oct 26, 10:15 AM ET. Market open.

Summary

Previous Close
$3.77
Open
$3.62
Day's Range
$3.53 – $4.02
52 Week Range
$3.01 – $16.44
Volume
5,571
Avg. Volume
29,327
Market Cap
$38.61M
Beta (5Y Monthly)
1.18
PE Ratio (TTM)
5.71
EPS (TTM)
$7.25
Earnings Date
Nov 12, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$12.50

Profile: DarioHealth Corp.

Sector
Healthcare
Industry
Medical - Specialties
Full-time employees
163
CEO
Erez Raphael

DarioHealth Corp. is a digital therapeutics enterprise operating across the United States, Canada, the European Union, Australia, and New Zealand. The company delivers a suite of digital health solutions, including its 'Dario' metabolic programs designed to address conditions like diabetes, hypertension, and weight management. They also offer 'Dario Musculoskeletal' for preventing and treating common MSK conditions, and 'Dario' behavioral health solutions to improve access to evidence-based care.

Earnings

Next report: Thu, Nov 12, 2026
EPS estimate -$0.51 · Revenue est. $5.24M
DateEst.Actual
Aug 11, 2026-$1.22-$0.85Beat
May 13, 2026-$1.09-$0.81Beat
Mar 19, 2026-$2.44-$0.80Beat
Nov 13, 2025-$3.97-$1.85Beat
Aug 12, 2025-$2.20-$2.40Miss
May 14, 2025-$1.40-$1.20Beat

Analyst view

Consensus price target
$12.50 ▲ +217.3%
Range $7.50 – $16.00
Rating: Buy
Buy 89% · Hold 11% · Sell 0%

Get free alerts on DRIO and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.